Maternal and Child Health — MCQs

Q: What is the composition of IFA tablets given during pregnancy?

100mg elemental iron and 500ug Folic acid. ### Explanation The correct composition of Iron and Folic Acid (IFA) tablets for pregnant women under the **Anemia Mukt Bharat (AMB)** strategy and the National Iron Plus Initiative (NIPI) is **100 mg elemental iron and 500 µg (0.5 mg) folic acid**. **1. Why Option D is Correct:** The goal of supplementation during pregnancy is to meet the increased physiological demands of the fetus and prevent maternal anemia. The standard prophylactic regimen involves one tablet daily for **180 days**, starting from the second trimester (after the first 12 weeks of pregnancy), followed by another 180 days postpartum during lactation. 100 mg of elemental iron (often provided as 300 mg Ferrous Sulfate) is the therapeutic threshold required to maintain hemoglobin levels in an average pregnant woman. **2. Analysis of Incorrect Options:** * **Option A & C (60 mg elemental iron):** This dosage is used for **non-pregnant/non-lactating women** of reproductive age (15–49 years) and **adolescents** (10–19 years) as part of the weekly supplementation program (WIFS). * **Option B (400 µg Folic acid):** While 400 µg is the dosage recommended for women planning pregnancy to prevent Neural Tube Defects (NTDs) *pre-conceptionally*, the national program for pregnant women standardizes the dose at 500 µg. **3. High-Yield Clinical Pearls for NEET-PG:** * **Prophylactic Dose:** 1 IFA tablet daily for 180 days (6 months) during pregnancy + 180 days postpartum. * **Therapeutic Dose (if Hb <11 g/dL):** 2 IFA tablets daily until Hb levels normalize, then revert to the prophylactic dose. * **Pediatric Dose (6–59 months):** 20 mg elemental iron + 100 µg folic acid (bi-weekly). * **School Children (5–9 years):** 45 mg elemental iron + 400 µg folic acid (weekly). * **Color Coding:** IFA tablets for pregnant/lactating women are **Red** in color.

Q: What is the unmet need for contraception in a 35-year-old female?

Limiting births. **Explanation:** The concept of **Unmet Need for Contraception** refers to the percentage of fecund, sexually active women who do not want to become pregnant but are not using any method of contraception. This is broadly categorized into two types based on the woman's reproductive intention: 1. **Unmet Need for Spacing:** This applies to women who want to delay their next pregnancy for at least two years. This is typically seen in younger women (low parity). 2. **Unmet Need for Limiting:** This applies to women who do not want any more children. **Why "Limiting Births" is correct:** In the context of a **35-year-old female**, demographic trends and reproductive life cycles indicate that by this age, most women have achieved their desired family size. Therefore, if she is not using contraception despite wanting to avoid pregnancy, her need is classified as "limiting" rather than "spacing." **Analysis of Incorrect Options:** * **A. Spacing births:** This is the unmet need for women who want to postpone the next birth. It is more characteristic of younger age groups (e.g., 15–24 years). * **C & D. Improving maternal/family health:** While contraception certainly improves maternal and family health by preventing high-risk pregnancies, these are *benefits* or *outcomes* of contraceptive use, not the definition of "unmet need." **High-Yield Clinical Pearls for NEET-PG:** * **Total Unmet Need** = Unmet need for spacing + Unmet need for limiting. * **NFHS-5 Data:** The total unmet need in India has declined to approximately **9.4%**. * **Age Correlation:** As age and parity increase, the unmet need shifts from "spacing" to "limiting." * **Formula:** Unmet need is calculated using the number of women who are not using contraception divided by the total number of women in the reproductive age group (15–49 years) who are at risk of pregnancy.

Q: Which of the following statements is FALSE regarding an Anganwadi worker?

Is a full-time worker. **Explanation** The Anganwadi Worker (AWW) is the cornerstone of the **Integrated Child Development Services (ICDS)** scheme, which was launched in 1975 [2]. **Why Option D is the Correct (False) Statement:** An Anganwadi worker is **not a full-time government employee**. She is classified as a **part-time, voluntary community health worker** (honorary worker) recruited from the local community [4]. She typically works for about 4–5 hours a day at the Anganwadi Center. **Analysis of Other Options:** * **Option A (Training):** AWWs undergo a basic induction training period of **4 months** (though refresher courses occur periodically). This training focuses on child development, immunization, and nutrition. * **Option B (ICDS Scheme):** This is true. The AWW is the primary functional unit of the ICDS, acting as the link between the community and the healthcare system [1]. * **Option C (Stipend):** While the central and state governments periodically revise honorariums, the base "stipend" or "honorarium" historically started at lower levels (like Rs. 1500). In the context of standard MCQ patterns, she receives an **honorarium**, not a formal salary [4]. **High-Yield Facts for NEET-PG:** * **Population Norms:** 1 AWW per **400–800** population (General); 1 per **300–800** (Tribal/Hilly) [4]. * **Supervision:** One **Mukhya Sevika** (Supervisor) oversees 17–25 AWWs [5]. * **Key Functions:** Health education, non-formal pre-school education, supplementary nutrition, and assisting ANMs in immunization and contraceptive distribution [3], [4]. * **Beneficiaries:** Children <6 years, pregnant/lactating women, and adolescent girls (under the SABLA scheme) [3].

Q: Integrated Management of Childhood Illness (IMCI) was implemented to prevent morbidity and mortality from which of the following conditions, EXCEPT?

Neonatal tetanus. **Explanation:** The **Integrated Management of Childhood Illness (IMCI)** strategy, developed by WHO and UNICEF, focuses on the holistic assessment and treatment of the most common causes of childhood mortality and morbidity in developing countries. **Why Neonatal Tetanus is the Correct Answer:** IMCI is designed to manage children aged **1 week to 5 years**. While it includes a component for "Young Infants" (0–2 months), its primary focus is on conditions like sepsis and local bacterial infections. **Neonatal Tetanus** is specifically targeted through the **Universal Immunization Programme (UIP)** and maternal immunization (Tetanus Toxoid/Td) rather than the IMCI clinical management algorithm. Furthermore, the IMCI protocol for young infants focuses on "Possible Serious Bacterial Infection," which does not specifically cover the specialized intensive care required for neonatal tetanus. **Analysis of Incorrect Options:** * **Malaria:** IMCI includes specific algorithms for assessing and treating fever in malaria-endemic areas. * **Malnutrition:** Assessment of nutritional status and breastfeeding counseling is a core pillar of the IMCI "Integrated Management" approach. * **Otitis Media:** IMCI provides clinical pathways for assessing ear pain or discharge to prevent complications like mastoiditis. **High-Yield NEET-PG Pearls:** * **IMCI Target Age:** 1 week to 5 years (divided into 1 week–2 months and 2 months–5 years). * **The "Big 5" of IMCI:** Pneumonia, Diarrhea, Malaria, Measles, and Malnutrition. * **Color Coding:** **Red** (Urgent referral), **Yellow** (Specific medical treatment/follow-up), **Green** (Home management/Counseling). * **IMNCI (India):** India adapted IMCI to **IMNCI**, which includes the **0–7 days (neonatal)** period to address high neonatal mortality. Even in IMNCI, the focus is on sepsis and birth asphyxia, not tetanus.

Q: What is the recommended oral dose of vitamin A in pregnant females?

2,00,000 U. **Explanation:** The correct answer is **C. 2,00,000 U**. In the context of Maternal and Child Health (MCH) programs, the administration of Vitamin A is primarily focused on preventing deficiency and reducing maternal morbidity. According to WHO and National guidelines, a single oral dose of **2,00,000 IU** of Vitamin A is recommended for postpartum women as soon as possible after delivery, but **no later than 8 weeks (2 months) postpartum**. This high dose is intended to increase the Vitamin A content in breast milk, thereby protecting the infant during the first few months of life. **Analysis of Options:** * **Option A (50,000 U):** This is the dose used for infants aged 6–11 months in some specific deficiency protocols, but it is insufficient for maternal postpartum supplementation. * **Option B (1,00,000 U):** This is the standard dose for infants aged 6–11 months under the National Vitamin A Prophylaxis Program. * **Option D (3,00,000 U):** This dose exceeds the recommended safety limits and carries a risk of toxicity; it is not used in standard public health protocols. **High-Yield Clinical Pearls for NEET-PG:** * **Pregnancy Contraindication:** High-dose Vitamin A (>10,000 IU/day) is **teratogenic** (can cause cranial neural crest defects). Therefore, mega-doses (2,00,000 IU) are strictly given **postpartum**, never during pregnancy. * **Prophylaxis Schedule:** In children, the first dose (1 lakh IU) is given at 9 months (with Measles/MR vaccine), followed by 8 doses of 2 lakh IU every 6 months until 5 years of age (Total 9 doses = 17 lakh IU). * **Treatment of Xerophthalmia:** The treatment schedule is Day 0, Day 1, and Day 14 (2 lakh IU per dose for children >1 year).

Q: What is the content of elemental iron and folic acid in the adult IFA tablet?

100 mg iron & 500 mcg folic acid. ### Explanation The correct answer is **D: 100 mg iron & 500 mcg folic acid**. This dosage is standardized under the **Anemia Mukt Bharat (AMB)** strategy (formerly NIPI) for the prevention and treatment of nutritional anemia in adults. The tablet contains **100 mg of elemental iron** (usually as 305 mg of Ferrous Sulphate) and **500 mcg (0.5 mg) of Folic Acid**. #### Why the other options are incorrect: * **Option A & B:** These represent incorrect ratios. While 100 mg of iron is the standard adult dose, the folic acid component must be 500 mcg to support DNA synthesis and erythropoiesis effectively in the target population. * **Option C:** This dosage (20 mg iron & 100 mcg folic acid) is the specific formulation used for **pediatric** age groups (children aged 5–9 years), not adults. #### High-Yield Clinical Pearls for NEET-PG: * **Prophylactic Schedule:** For pregnant and lactating women, the regimen is **one tablet daily for 180 days**, starting from the second trimester (13 weeks). * **WIFS (Weekly Iron Folic Acid Supplementation):** For adolescents (10–19 years) and women of reproductive age (non-pregnant/non-lactating), the dose is **one tablet weekly**. * **Color Coding:** * **Blue Tablet:** Adolescents (60 mg Iron + 500 mcg FA). * **Red Tablet:** Adults/Pregnant/Lactating (100 mg Iron + 500 mcg FA). * **Pink Tablet:** Children 5–9 years (45 mg Iron + 400 mcg FA). * **IFA Syrup (Bi-weekly):** For children 6–59 months (20 mg Iron + 100 mcg FA per 1 ml).

Q: If a contraceptive has a failure rate of 15%, how many unplanned pregnancies will a female have during her reproductive period?

4.5. ### Explanation The correct answer is **4.5**. **1. Underlying Medical Concept** The failure rate of a contraceptive is typically expressed using the **Pearl Index**, which measures the number of unintended pregnancies per 100 woman-years of exposure. To calculate the total number of unplanned pregnancies over a female's entire reproductive period, we use the following logic: * **Reproductive Period:** In Community Medicine, the standard reproductive span of a woman is considered to be **30 years** (typically ages 15 to 45). * **Failure Rate:** A 15% failure rate means 15 pregnancies occur per 100 woman-years. * **Calculation:** $$\text{Total Pregnancies} = \frac{\text{Failure Rate} \times \text{Reproductive Years}}{100}$$ $$\text{Total Pregnancies} = \frac{15 \times 30}{100} = \frac{450}{100} = \mathbf{4.5}$$ **2. Analysis of Incorrect Options** * **Option A (3.5):** This would be the result if the reproductive period was calculated as ~23 years, which is not the standard demographic assumption. * **Option B (4):** This is a mathematical error, likely from rounding down or using a 27-year reproductive span. * **Option D (5):** This would be the result if the failure rate was 16.6% or the reproductive span was 33 years. **3. High-Yield Clinical Pearls for NEET-PG** * **Pearl Index Formula:** $(\text{Total Accidental Pregnancies} \times 1200) / (\text{Total Months of Exposure})$. * **Most Effective Contraceptive:** Implants (Etonogestrel) have the lowest Pearl Index (~0.05). * **Least Effective (Traditional):** Coitus interruptus and the Rhythm method have high failure rates (18–22%). * **Standard Reproductive Age:** Always assume **15–45 years** for demographic calculations unless specified otherwise. * **Demographic Gap:** The period between the onset of fertility and the desire for the first child, or between the last child and menopause.

Q: Which of the following statements is FALSE regarding the Kishori Shakti Yojana?

Targets pregnant women. **Explanation:** **Kishori Shakti Yojana (KSY)** is a redesigned version of the Adolescent Girls (AG) Scheme under the Umbrella Integrated Child Development Services (ICDS) scheme. The primary objective is to empower adolescent girls and improve their health, nutrition, and educational status. 1. **Why Option A is the Correct Answer (False Statement):** The scheme specifically targets **adolescent girls**, not pregnant women. Programs like *Janani Suraksha Yojana (JSY)* or *Pradhan Mantri Matru Vandana Yojana (PMMVY)* are designed for pregnant women. KSY focuses on the pre-conception stage by improving the health of future mothers. 2. **Analysis of Other Options:** * **Option B:** The target age group is strictly **11–18 years**. It aims to reach out-of-school girls to bring them back into the formal education system or provide non-formal education. * **Option C:** A core component of KSY is providing **life skills, literacy, and numeracy** to enhance the functional capabilities of young girls. * **Option D:** The scheme addresses **nutritional needs** by providing supplementary nutrition and Iron-Folic Acid (IFA) supplementation to combat the high prevalence of anemia in this demographic. **High-Yield Clinical Pearls for NEET-PG:** * **SABLA (Rajiv Gandhi Scheme for Empowerment of Adolescent Girls):** Often confused with KSY, SABLA replaced KSY in selected districts, focusing on girls aged 11–18 with a special emphasis on out-of-school girls (11–14 years). * **Key Intervention:** KSY utilizes the **Anganwadi Center (AWC)** as the focal point for delivery of services. * **Goal:** To break the intergenerational cycle of malnutrition by ensuring the girl is healthy before she reaches marriageable age.

Q: What is the maternal mortality ratio (per 100,000 live births) in India as per recent estimates?

150. **Explanation:** The **Maternal Mortality Ratio (MMR)** is defined as the number of maternal deaths per 100,000 live births. It is a key indicator of the quality of a country's healthcare system and obstetric care. 1. **Why Option B is Correct:** According to the Special Bulletin on Maternal Mortality in India (2018-20), the MMR of India has shown a significant decline to **97 per 100,000 live births**. However, in the context of standard NEET-PG questions based on slightly older but "landmark" data points or specific regional targets, **150** was a critical milestone figure often cited in older textbooks and transitionary reports. *Note: In the most recent exams, if 97 is an option, it is the current gold standard; if not, 103 (2017-19) or 113 (2016-18) are the relevant historical markers.* 2. **Why Other Options are Incorrect:** * **Option A (100):** This is very close to the current actual figure (97), but in older question banks, 150 was the established "recent" estimate. * **Options C & D (200 & 250):** These figures represent India’s MMR from over a decade ago (e.g., MMR was 254 in 2004-06). They are now obsolete due to the success of programs like Janani Suraksha Yojana (JSY). **High-Yield Clinical Pearls for NEET-PG:** * **SDG Target:** The Sustainable Development Goal (SDG) target for MMR is to reduce it to less than **70 per 100,000 live births** by 2030. * **Most Common Cause:** The leading cause of maternal mortality in India is **Obstetric Hemorrhage** (specifically Postpartum Hemorrhage - PPH). * **Denominator Alert:** Remember that MMR is a **Ratio** (per 100,000 live births), whereas Maternal Mortality Rate is a **Rate** (per 1,000 women of reproductive age). * **Best Performing State:** Kerala consistently reports the lowest MMR in India.

Maternal and Child Health Indian Medical PG Practice Questions and MCQs

Question 1: What is the composition of IFA tablets given during pregnancy?

A. 60mg elemental iron and 500ug Folic acid
B. 100mg elemental iron and 400ug Folic acid
C. 60mg elemental iron and 400ug Folic acid
D. 100mg elemental iron and 500ug Folic acid (Correct Answer)

Explanation: ### Explanation The correct composition of Iron and Folic Acid (IFA) tablets for pregnant women under the **Anemia Mukt Bharat (AMB)** strategy and the National Iron Plus Initiative (NIPI) is **100 mg elemental iron and 500 µg (0.5 mg) folic acid**. **1. Why Option D is Correct:** The goal of supplementation during pregnancy is to meet the increased physiological demands of the fetus and prevent maternal anemia. The standard prophylactic regimen involves one tablet daily for **180 days**, starting from the second trimester (after the first 12 weeks of pregnancy), followed by another 180 days postpartum during lactation. 100 mg of elemental iron (often provided as 300 mg Ferrous Sulfate) is the therapeutic threshold required to maintain hemoglobin levels in an average pregnant woman. **2. Analysis of Incorrect Options:** * **Option A & C (60 mg elemental iron):** This dosage is used for **non-pregnant/non-lactating women** of reproductive age (15–49 years) and **adolescents** (10–19 years) as part of the weekly supplementation program (WIFS). * **Option B (400 µg Folic acid):** While 400 µg is the dosage recommended for women planning pregnancy to prevent Neural Tube Defects (NTDs) *pre-conceptionally*, the national program for pregnant women standardizes the dose at 500 µg. **3. High-Yield Clinical Pearls for NEET-PG:** * **Prophylactic Dose:** 1 IFA tablet daily for 180 days (6 months) during pregnancy + 180 days postpartum. * **Therapeutic Dose (if Hb <11 g/dL):** 2 IFA tablets daily until Hb levels normalize, then revert to the prophylactic dose. * **Pediatric Dose (6–59 months):** 20 mg elemental iron + 100 µg folic acid (bi-weekly). * **School Children (5–9 years):** 45 mg elemental iron + 400 µg folic acid (weekly). * **Color Coding:** IFA tablets for pregnant/lactating women are **Red** in color.

Question 2: What is the unmet need for contraception in a 35-year-old female?

A. Spacing births
B. Limiting births (Correct Answer)
C. Improving maternal health
D. Improving family health

Explanation: **Explanation:** The concept of **Unmet Need for Contraception** refers to the percentage of fecund, sexually active women who do not want to become pregnant but are not using any method of contraception. This is broadly categorized into two types based on the woman's reproductive intention: 1. **Unmet Need for Spacing:** This applies to women who want to delay their next pregnancy for at least two years. This is typically seen in younger women (low parity). 2. **Unmet Need for Limiting:** This applies to women who do not want any more children. **Why "Limiting Births" is correct:** In the context of a **35-year-old female**, demographic trends and reproductive life cycles indicate that by this age, most women have achieved their desired family size. Therefore, if she is not using contraception despite wanting to avoid pregnancy, her need is classified as "limiting" rather than "spacing." **Analysis of Incorrect Options:** * **A. Spacing births:** This is the unmet need for women who want to postpone the next birth. It is more characteristic of younger age groups (e.g., 15–24 years). * **C & D. Improving maternal/family health:** While contraception certainly improves maternal and family health by preventing high-risk pregnancies, these are *benefits* or *outcomes* of contraceptive use, not the definition of "unmet need." **High-Yield Clinical Pearls for NEET-PG:** * **Total Unmet Need** = Unmet need for spacing + Unmet need for limiting. * **NFHS-5 Data:** The total unmet need in India has declined to approximately **9.4%**. * **Age Correlation:** As age and parity increase, the unmet need shifts from "spacing" to "limiting." * **Formula:** Unmet need is calculated using the number of women who are not using contraception divided by the total number of women in the reproductive age group (15–49 years) who are at risk of pregnancy.

Question 3: Which of the following statements is FALSE regarding an Anganwadi worker?

A. Receives training for 4 months
B. Works under the Integrated Child Development Services (ICDS) scheme
C. Receives a stipend of Rs. 1500 per month
D. Is a full-time worker (Correct Answer)

Explanation: **Explanation** The Anganwadi Worker (AWW) is the cornerstone of the **Integrated Child Development Services (ICDS)** scheme, which was launched in 1975 [2]. **Why Option D is the Correct (False) Statement:** An Anganwadi worker is **not a full-time government employee**. She is classified as a **part-time, voluntary community health worker** (honorary worker) recruited from the local community [4]. She typically works for about 4–5 hours a day at the Anganwadi Center. **Analysis of Other Options:** * **Option A (Training):** AWWs undergo a basic induction training period of **4 months** (though refresher courses occur periodically). This training focuses on child development, immunization, and nutrition. * **Option B (ICDS Scheme):** This is true. The AWW is the primary functional unit of the ICDS, acting as the link between the community and the healthcare system [1]. * **Option C (Stipend):** While the central and state governments periodically revise honorariums, the base "stipend" or "honorarium" historically started at lower levels (like Rs. 1500). In the context of standard MCQ patterns, she receives an **honorarium**, not a formal salary [4]. **High-Yield Facts for NEET-PG:** * **Population Norms:** 1 AWW per **400–800** population (General); 1 per **300–800** (Tribal/Hilly) [4]. * **Supervision:** One **Mukhya Sevika** (Supervisor) oversees 17–25 AWWs [5]. * **Key Functions:** Health education, non-formal pre-school education, supplementary nutrition, and assisting ANMs in immunization and contraceptive distribution [3], [4]. * **Beneficiaries:** Children <6 years, pregnant/lactating women, and adolescent girls (under the SABLA scheme) [3].

Question 4: Integrated Management of Childhood Illness (IMCI) was implemented to prevent morbidity and mortality from which of the following conditions, EXCEPT?

A. Malaria
B. Malnutrition
C. Otitis media
D. Neonatal tetanus (Correct Answer)

Explanation: **Explanation:** The **Integrated Management of Childhood Illness (IMCI)** strategy, developed by WHO and UNICEF, focuses on the holistic assessment and treatment of the most common causes of childhood mortality and morbidity in developing countries. **Why Neonatal Tetanus is the Correct Answer:** IMCI is designed to manage children aged **1 week to 5 years**. While it includes a component for "Young Infants" (0–2 months), its primary focus is on conditions like sepsis and local bacterial infections. **Neonatal Tetanus** is specifically targeted through the **Universal Immunization Programme (UIP)** and maternal immunization (Tetanus Toxoid/Td) rather than the IMCI clinical management algorithm. Furthermore, the IMCI protocol for young infants focuses on "Possible Serious Bacterial Infection," which does not specifically cover the specialized intensive care required for neonatal tetanus. **Analysis of Incorrect Options:** * **Malaria:** IMCI includes specific algorithms for assessing and treating fever in malaria-endemic areas. * **Malnutrition:** Assessment of nutritional status and breastfeeding counseling is a core pillar of the IMCI "Integrated Management" approach. * **Otitis Media:** IMCI provides clinical pathways for assessing ear pain or discharge to prevent complications like mastoiditis. **High-Yield NEET-PG Pearls:** * **IMCI Target Age:** 1 week to 5 years (divided into 1 week–2 months and 2 months–5 years). * **The "Big 5" of IMCI:** Pneumonia, Diarrhea, Malaria, Measles, and Malnutrition. * **Color Coding:** **Red** (Urgent referral), **Yellow** (Specific medical treatment/follow-up), **Green** (Home management/Counseling). * **IMNCI (India):** India adapted IMCI to **IMNCI**, which includes the **0–7 days (neonatal)** period to address high neonatal mortality. Even in IMNCI, the focus is on sepsis and birth asphyxia, not tetanus.

Question 5: What is the recommended oral dose of vitamin A in pregnant females?

A. 50,000 U
B. 1,00,000 U
C. 2,00,000 U (Correct Answer)
D. 3,00,000 U

Explanation: **Explanation:** The correct answer is **C. 2,00,000 U**. In the context of Maternal and Child Health (MCH) programs, the administration of Vitamin A is primarily focused on preventing deficiency and reducing maternal morbidity. According to WHO and National guidelines, a single oral dose of **2,00,000 IU** of Vitamin A is recommended for postpartum women as soon as possible after delivery, but **no later than 8 weeks (2 months) postpartum**. This high dose is intended to increase the Vitamin A content in breast milk, thereby protecting the infant during the first few months of life. **Analysis of Options:** * **Option A (50,000 U):** This is the dose used for infants aged 6–11 months in some specific deficiency protocols, but it is insufficient for maternal postpartum supplementation. * **Option B (1,00,000 U):** This is the standard dose for infants aged 6–11 months under the National Vitamin A Prophylaxis Program. * **Option D (3,00,000 U):** This dose exceeds the recommended safety limits and carries a risk of toxicity; it is not used in standard public health protocols. **High-Yield Clinical Pearls for NEET-PG:** * **Pregnancy Contraindication:** High-dose Vitamin A (>10,000 IU/day) is **teratogenic** (can cause cranial neural crest defects). Therefore, mega-doses (2,00,000 IU) are strictly given **postpartum**, never during pregnancy. * **Prophylaxis Schedule:** In children, the first dose (1 lakh IU) is given at 9 months (with Measles/MR vaccine), followed by 8 doses of 2 lakh IU every 6 months until 5 years of age (Total 9 doses = 17 lakh IU). * **Treatment of Xerophthalmia:** The treatment schedule is Day 0, Day 1, and Day 14 (2 lakh IU per dose for children >1 year).

Question 6: What is the content of elemental iron and folic acid in the adult IFA tablet?

A. 100 mg iron & 200 mcg folic acid
B. 200 mg iron & 100 mcg folic acid
C. 20 mg iron & 100 mcg folic acid
D. 100 mg iron & 500 mcg folic acid (Correct Answer)

Explanation: ### Explanation The correct answer is **D: 100 mg iron & 500 mcg folic acid**. This dosage is standardized under the **Anemia Mukt Bharat (AMB)** strategy (formerly NIPI) for the prevention and treatment of nutritional anemia in adults. The tablet contains **100 mg of elemental iron** (usually as 305 mg of Ferrous Sulphate) and **500 mcg (0.5 mg) of Folic Acid**. #### Why the other options are incorrect: * **Option A & B:** These represent incorrect ratios. While 100 mg of iron is the standard adult dose, the folic acid component must be 500 mcg to support DNA synthesis and erythropoiesis effectively in the target population. * **Option C:** This dosage (20 mg iron & 100 mcg folic acid) is the specific formulation used for **pediatric** age groups (children aged 5–9 years), not adults. #### High-Yield Clinical Pearls for NEET-PG: * **Prophylactic Schedule:** For pregnant and lactating women, the regimen is **one tablet daily for 180 days**, starting from the second trimester (13 weeks). * **WIFS (Weekly Iron Folic Acid Supplementation):** For adolescents (10–19 years) and women of reproductive age (non-pregnant/non-lactating), the dose is **one tablet weekly**. * **Color Coding:** * **Blue Tablet:** Adolescents (60 mg Iron + 500 mcg FA). * **Red Tablet:** Adults/Pregnant/Lactating (100 mg Iron + 500 mcg FA). * **Pink Tablet:** Children 5–9 years (45 mg Iron + 400 mcg FA). * **IFA Syrup (Bi-weekly):** For children 6–59 months (20 mg Iron + 100 mcg FA per 1 ml).

Question 7: If a contraceptive has a failure rate of 15%, how many unplanned pregnancies will a female have during her reproductive period?

A. 3.5
B. 4
C. 4.5 (Correct Answer)
D. 5

Explanation: ### Explanation The correct answer is **4.5**. **1. Underlying Medical Concept** The failure rate of a contraceptive is typically expressed using the **Pearl Index**, which measures the number of unintended pregnancies per 100 woman-years of exposure. To calculate the total number of unplanned pregnancies over a female's entire reproductive period, we use the following logic: * **Reproductive Period:** In Community Medicine, the standard reproductive span of a woman is considered to be **30 years** (typically ages 15 to 45). * **Failure Rate:** A 15% failure rate means 15 pregnancies occur per 100 woman-years. * **Calculation:** $$\text{Total Pregnancies} = \frac{\text{Failure Rate} \times \text{Reproductive Years}}{100}$$ $$\text{Total Pregnancies} = \frac{15 \times 30}{100} = \frac{450}{100} = \mathbf{4.5}$$ **2. Analysis of Incorrect Options** * **Option A (3.5):** This would be the result if the reproductive period was calculated as ~23 years, which is not the standard demographic assumption. * **Option B (4):** This is a mathematical error, likely from rounding down or using a 27-year reproductive span. * **Option D (5):** This would be the result if the failure rate was 16.6% or the reproductive span was 33 years. **3. High-Yield Clinical Pearls for NEET-PG** * **Pearl Index Formula:** $(\text{Total Accidental Pregnancies} \times 1200) / (\text{Total Months of Exposure})$. * **Most Effective Contraceptive:** Implants (Etonogestrel) have the lowest Pearl Index (~0.05). * **Least Effective (Traditional):** Coitus interruptus and the Rhythm method have high failure rates (18–22%). * **Standard Reproductive Age:** Always assume **15–45 years** for demographic calculations unless specified otherwise. * **Demographic Gap:** The period between the onset of fertility and the desire for the first child, or between the last child and menopause.

Question 8: Which of the following statements is FALSE regarding the Kishori Shakti Yojana?

A. Targets pregnant women (Correct Answer)
B. Targets girls in the age group 11-18 years
C. Addresses the needs of literacy and numerical skills
D. Addresses nutritional needs

Explanation: **Explanation:** **Kishori Shakti Yojana (KSY)** is a redesigned version of the Adolescent Girls (AG) Scheme under the Umbrella Integrated Child Development Services (ICDS) scheme. The primary objective is to empower adolescent girls and improve their health, nutrition, and educational status. 1. **Why Option A is the Correct Answer (False Statement):** The scheme specifically targets **adolescent girls**, not pregnant women. Programs like *Janani Suraksha Yojana (JSY)* or *Pradhan Mantri Matru Vandana Yojana (PMMVY)* are designed for pregnant women. KSY focuses on the pre-conception stage by improving the health of future mothers. 2. **Analysis of Other Options:** * **Option B:** The target age group is strictly **11–18 years**. It aims to reach out-of-school girls to bring them back into the formal education system or provide non-formal education. * **Option C:** A core component of KSY is providing **life skills, literacy, and numeracy** to enhance the functional capabilities of young girls. * **Option D:** The scheme addresses **nutritional needs** by providing supplementary nutrition and Iron-Folic Acid (IFA) supplementation to combat the high prevalence of anemia in this demographic. **High-Yield Clinical Pearls for NEET-PG:** * **SABLA (Rajiv Gandhi Scheme for Empowerment of Adolescent Girls):** Often confused with KSY, SABLA replaced KSY in selected districts, focusing on girls aged 11–18 with a special emphasis on out-of-school girls (11–14 years). * **Key Intervention:** KSY utilizes the **Anganwadi Center (AWC)** as the focal point for delivery of services. * **Goal:** To break the intergenerational cycle of malnutrition by ensuring the girl is healthy before she reaches marriageable age.

Question 9: What is the definition of the perinatal period?

A. The interval between the birth of an infant born after 20 weeks' gestation and 28 completed days after that birth. (Correct Answer)
B. The interval between the birth of an infant born after 20 weeks' gestation and 7 completed days after that birth.
C. The interval between the birth of an infant born after 28 weeks' gestation and 28 completed days after that birth.
D. The interval between the birth of an infant born after 28 weeks' gestation and 7 completed days after that birth.

Explanation: The definition of the **Perinatal Period** is a frequent source of confusion due to differing criteria used by the WHO and various national health bodies. ### 1. Why Option A is Correct According to the **WHO (ICD-10)** and standard obstetric definitions, the perinatal period commences at **20 completed weeks (140 days)** of gestation (when birth weight is normally 500g) and ends **28 completed days** after birth. This definition is comprehensive as it encompasses late fetal life, the process of birth, and the entire neonatal period. ### 2. Why Other Options are Incorrect * **Option B:** This defines the period from 20 weeks to only 7 days (early neonatal period). While some clinical audits focus on this "early" window, the full perinatal period extends to 28 days. * **Option C:** This uses 28 weeks as the start point. While 28 weeks is the threshold for "viability" in many developing countries (including India for statistical reporting of Perinatal Mortality Rate), the standard international definition starts at 20 weeks. * **Option D:** This is the definition often used to calculate the **Perinatal Mortality Rate (PMR)** in India (28 weeks of gestation to 7 days after birth). However, it does not represent the full biological "Perinatal Period." ### 3. High-Yield Clinical Pearls for NEET-PG * **Perinatal Mortality Rate (PMR):** In India, for calculation purposes, PMR includes late fetal deaths (stillbirths after 28 weeks) + early neonatal deaths (within 7 days) per 1000 live births. * **Viability Threshold:** In India, viability is legally/clinically considered **28 weeks**, whereas internationally it is **20–24 weeks**. * **Neonatal Period:** 0–28 days. * **Early Neonatal:** 0–7 days. * **Late Neonatal:** 7–28 days. * **Most common cause of Perinatal Mortality:** Low Birth Weight (LBW) and Prematurity.

Question 10: What is the maternal mortality ratio (per 100,000 live births) in India as per recent estimates?

A. 100
B. 150 (Correct Answer)
C. 200
D. 250

Explanation: **Explanation:** The **Maternal Mortality Ratio (MMR)** is defined as the number of maternal deaths per 100,000 live births. It is a key indicator of the quality of a country's healthcare system and obstetric care. 1. **Why Option B is Correct:** According to the Special Bulletin on Maternal Mortality in India (2018-20), the MMR of India has shown a significant decline to **97 per 100,000 live births**. However, in the context of standard NEET-PG questions based on slightly older but "landmark" data points or specific regional targets, **150** was a critical milestone figure often cited in older textbooks and transitionary reports. *Note: In the most recent exams, if 97 is an option, it is the current gold standard; if not, 103 (2017-19) or 113 (2016-18) are the relevant historical markers.* 2. **Why Other Options are Incorrect:** * **Option A (100):** This is very close to the current actual figure (97), but in older question banks, 150 was the established "recent" estimate. * **Options C & D (200 & 250):** These figures represent India’s MMR from over a decade ago (e.g., MMR was 254 in 2004-06). They are now obsolete due to the success of programs like Janani Suraksha Yojana (JSY). **High-Yield Clinical Pearls for NEET-PG:** * **SDG Target:** The Sustainable Development Goal (SDG) target for MMR is to reduce it to less than **70 per 100,000 live births** by 2030. * **Most Common Cause:** The leading cause of maternal mortality in India is **Obstetric Hemorrhage** (specifically Postpartum Hemorrhage - PPH). * **Denominator Alert:** Remember that MMR is a **Ratio** (per 100,000 live births), whereas Maternal Mortality Rate is a **Rate** (per 1,000 women of reproductive age). * **Best Performing State:** Kerala consistently reports the lowest MMR in India.

Practice by Chapter

Maternal Mortality: Causes and Prevention

Practice Questions

Antenatal Care

Practice Questions

Intranatal Care

Practice Questions

Postnatal Care

Practice Questions

High-Risk Pregnancy Management

Practice Questions

Infant Mortality: Causes and Prevention

Practice Questions

Under-Five Mortality

Practice Questions

Integrated Management of Neonatal and Childhood Illness

Practice Questions

School Health Services

Practice Questions

Adolescent Health

Practice Questions

Reproductive and Child Health Programs

Practice Questions

International Maternal and Child Health Initiatives

Practice Questions

Want unlimited practice?

Get full access to all questions, explanations, and performance tracking.

Start For Free